Literature DB >> 7947744

Mechanism of mevalonate pyrophosphate decarboxylase: evidence for a carbocationic transition state.

S Dhe-Paganon1, J Magrath, R H Abeles.   

Abstract

Mevalonate pyrophosphate decarboxylase catalyzes the decarboxylation of mevalonate pyrophosphate to isopentyl pyrophosphate. The mechanism of action of this enzyme was investigated to elucidate the mechanism of inhibition by 3-hydroxy-3-(fluoromethyl)-5-pyrophosphopentanoic acid (II). It was previously found that II is a competitive inhibitor (Ki = 0.01 microM) of the enzyme reaction [Reardon, J.E., & Abeles, R.H. (1987) Biochemistry 26, 4717-4722; Nave, J.F., d'Orchymont, H., Ducep, J.B., Piriou, F., & Jung, M.J. (1985) Biochem. J. 227, 247-254]. We have now observed that II is decarboxylated 2500-fold more slowly than mevalonate pyrophosphate (3-hydroxy-3-methyl-5-pyrophosphopentanoic acid, I). The enzyme was exposed to saturating concentrations of II and ATP and then passed through a Penefsky column to remove excess substrate. The enzyme was denatured immediately upon emerging from the Penefsky column. Nearly 1 equiv of both 3-phospho-3-(fluoromethyl)-5-pyrophosphopentanoic acid and ADP was bound to the enzyme. 3-Hydroxy-5-pyrophosphopentanoic acid (III) is phosphorylated at the secondary hydroxyl group and released from the enzyme without decarboxylation. This reaction is 30-fold slower than the rate of decarboxylation of I. The introduction of the 3-fluoromethyl group as well as the removal of the 3-methyl group results in low rates of decarboxylation. These substrate analogs have decreased electron density relative to the tertiary carbon of the substrate. Therefore, the transition state of the decarboxylation step has considerable carbocationic character. Further support for the carbocationic transition state is provided by the finding that N-methyl-N-carboxymethyl-2-pyrophosphoethanolamine (IV) inhibits the enzyme reaction with Ki = 0.75 microM. IV is probably a transition-state analog in which the positively charged nitrogen atom is analogous to the carbocation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947744     DOI: 10.1021/bi00249a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Probing ligand-binding pockets of the mevalonate pathway enzymes from Streptococcus pneumoniae.

Authors:  Scott T Lefurgy; Sofia B Rodriguez; Chan Sun Park; Sean Cahill; Richard B Silverman; Thomas S Leyh
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

2.  A whole-cell phenotypic screening platform for identifying methylerythritol phosphate pathway-selective inhibitors as novel antibacterial agents.

Authors:  Charles A Testa; L Jeffrey Johnson
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

3.  A preliminary crystallographic analysis of the putative mevalonate diphosphate decarboxylase from Trypanosoma brucei.

Authors:  Emma Byres; David M A Martin; William N Hunter
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-01

Review 4.  Mechanistic aspects of carotenoid biosynthesis.

Authors:  Alexander R Moise; Salim Al-Babili; Eleanore T Wurtzel
Journal:  Chem Rev       Date:  2013-10-31       Impact factor: 60.622

5.  A Single Amino Acid Mutation Converts (R)-5-Diphosphomevalonate Decarboxylase into a Kinase.

Authors:  Kento Motoyama; Hideaki Unno; Ai Hattori; Tomohiro Takaoka; Hiroshi Ishikita; Hiroshi Kawaide; Tohru Yoshimura; Hisashi Hemmi
Journal:  J Biol Chem       Date:  2016-12-21       Impact factor: 5.157

6.  A high-throughput screening campaign to identify inhibitors of DXP reductoisomerase (IspC) and MEP cytidylyltransferase (IspD).

Authors:  Amanda Haymond; Tyrone Dowdy; Chinchu Johny; Claire Johnson; Haley Ball; Allyson Dailey; Brandon Schweibenz; Karen Villarroel; Richard Young; Clark J Mantooth; Trishal Patel; Jessica Bases; Cynthia S Dowd; Robin D Couch
Journal:  Anal Biochem       Date:  2017-11-24       Impact factor: 3.365

7.  Mevalonate analogues as substrates of enzymes in the isoprenoid biosynthetic pathway of Streptococcus pneumoniae.

Authors:  Takashi Kudoh; Chan Sun Park; Scott T Lefurgy; Meihao Sun; Theodore Michels; Thomas S Leyh; Richard B Silverman
Journal:  Bioorg Med Chem       Date:  2009-12-24       Impact factor: 3.641

8.  Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.

Authors:  Natalia E Voynova; Zhuji Fu; Kevin P Battaile; Timothy J Herdendorf; Jung-Ja P Kim; Henry M Miziorko
Journal:  Arch Biochem Biophys       Date:  2008-09-18       Impact factor: 4.013

9.  Characterization of the Mycobacterium tuberculosis 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase: potential for drug development.

Authors:  Hyungjin Eoh; Amanda C Brown; Lori Buetow; William N Hunter; Tanya Parish; Devinder Kaur; Patrick J Brennan; Dean C Crick
Journal:  J Bacteriol       Date:  2007-10-05       Impact factor: 3.490

10.  Kinetic characterization and phosphoregulation of the Francisella tularensis 1-deoxy-D-xylulose 5-phosphate reductoisomerase (MEP synthase).

Authors:  Safdar Jawaid; Heather Seidle; Weidong Zhou; Hafsa Abdirahman; Maher Abadeer; Joseph H Hix; Monique L van Hoek; Robin D Couch
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.